Local economic planning to help end HIV in communities
Localized economic modeling to support implementation of the Ending the HIV Epidemic initiative
This project builds tools to help local health leaders plan cost-effective HIV prevention and care for communities hit hardest by HIV, including during COVID disruptions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Simon Fraser University NIH-funded |
| Lab location | 1 site (Burnaby, Canada) |
| Project ID | NIH-11170713 on NIH RePORTER |
What this research studies
Researchers are creating an integrated decision-making platform that models local HIV microepidemics, costs, and differences in health-system infrastructure across counties and states. The platform will combine local data on HIV cases, healthcare access, laws and policies, and COVID-19 impacts to estimate which prevention and treatment actions give the most benefit for the money. It will explicitly include steps and resource constraints needed for real-world implementation so programs can choose feasible options. The goal is to guide local planners in EHE-targeted areas to reduce new infections and improve care.
Who could benefit from this research
Good fit: People living with HIV or at high risk in EHE-targeted counties, cities, and rural-burden states would be the main groups to benefit indirectly and could be engaged for data or pilot activities.
Not a fit: People outside the targeted jurisdictions or those seeking direct clinical treatments rather than program-level planning improvements may not see direct benefit from this work.
Why it matters
Potential benefit: If successful, this could help local health programs use limited funding more effectively to prevent new HIV infections and improve care for people living with HIV.
How similar studies have performed: Economic and epidemic modeling has previously guided public-health resource decisions, though integrating detailed local implementation planning with COVID-era disruptions is a relatively new approach.
Where this research is happening
Burnaby, Canada
- Simon Fraser University — Burnaby, Canada (Active)
Researchers
- Principal investigator: Nosyk, Bohdan — Simon Fraser University
- Study coordinator: Nosyk, Bohdan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.